JP2025504936A5 - - Google Patents
Info
- Publication number
- JP2025504936A5 JP2025504936A5 JP2024544723A JP2024544723A JP2025504936A5 JP 2025504936 A5 JP2025504936 A5 JP 2025504936A5 JP 2024544723 A JP2024544723 A JP 2024544723A JP 2024544723 A JP2024544723 A JP 2024544723A JP 2025504936 A5 JP2025504936 A5 JP 2025504936A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- domain
- linker amino
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263304377P | 2022-01-28 | 2022-01-28 | |
| US63/304,377 | 2022-01-28 | ||
| PCT/US2023/011727 WO2023147042A2 (en) | 2022-01-28 | 2023-01-27 | Compositions, devices and methods for treating cns disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504936A JP2025504936A (ja) | 2025-02-19 |
| JP2025504936A5 true JP2025504936A5 (https=) | 2026-02-03 |
Family
ID=87472582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544723A Pending JP2025504936A (ja) | 2022-01-28 | 2023-01-27 | Ｃｎｓ障害を治療するための組成物、デバイス、及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250144174A1 (https=) |
| EP (1) | EP4469490A4 (https=) |
| JP (1) | JP2025504936A (https=) |
| CN (1) | CN118984840A (https=) |
| CA (1) | CA3249375A1 (https=) |
| WO (1) | WO2023147042A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202448926A (zh) | 2023-02-17 | 2024-12-16 | 比利時商艾伯霖克斯公司 | 結合新生兒fc受體之多肽 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014012082A2 (en) * | 2012-07-13 | 2014-01-16 | Zymeworks Inc. | Multivalent heteromultimer scaffold design an constructs |
| KR102497564B1 (ko) * | 2016-12-26 | 2023-02-07 | 제이씨알 파마 가부시키가이샤 | 혈액뇌관문을 통과하는 신규한 항인간 트랜스페린 수용체 항체 |
| US12344671B2 (en) * | 2018-04-24 | 2025-07-01 | National Research Council Of Canada | Blood-brain barrier transmigrating therapeutic compounds and uses thereof |
| UY38389A (es) * | 2018-09-27 | 2020-04-30 | Sigilon Therapeutics Inc | Dispositivos implantables para terapia celular y métodos relacionados |
| US20230123802A1 (en) * | 2019-03-27 | 2023-04-20 | Sigilon Therapeutics, Inc. | Compositions, devices, and methods for factor vii therapy |
-
2023
- 2023-01-27 CA CA3249375A patent/CA3249375A1/en active Pending
- 2023-01-27 JP JP2024544723A patent/JP2025504936A/ja active Pending
- 2023-01-27 CN CN202380021666.2A patent/CN118984840A/zh active Pending
- 2023-01-27 WO PCT/US2023/011727 patent/WO2023147042A2/en not_active Ceased
- 2023-01-27 US US18/833,641 patent/US20250144174A1/en active Pending
- 2023-01-27 EP EP23747643.7A patent/EP4469490A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5667171B2 (ja) | 二機能性ポリペプチド | |
| JP2025090743A5 (https=) | ||
| JP2014510518A5 (https=) | ||
| JP2020502051A5 (https=) | ||
| JP2023540732A5 (https=) | ||
| JP2019112445A5 (https=) | ||
| JP2015212284A5 (https=) | ||
| JP2013534812A5 (https=) | ||
| JP2018515088A5 (https=) | ||
| JP2006514607A5 (https=) | ||
| JP2014040483A5 (https=) | ||
| JP2002536960A5 (https=) | ||
| JP2010539921A5 (https=) | ||
| JP2023512454A5 (https=) | ||
| JP2009509535A5 (https=) | ||
| JP2019535321A5 (https=) | ||
| NO20063026L (no) | Antistoffer | |
| JP2023528204A5 (https=) | ||
| JP2010504336A5 (https=) | ||
| JP2025504936A5 (https=) | ||
| JP2016535741A5 (https=) | ||
| JP2015512247A5 (https=) | ||
| JP2020529845A5 (https=) | ||
| JP2019518713A5 (https=) | ||
| IL310164A (en) | Multi-chain chimeric polypeptides and use thereof in the treatment of liver diseases |